StonvexLoading…
StonvexStonvexStonvexCore line items from CPHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $983.54K | $4.14M | $2.92M | $2.16M |
Operating Income | $-1.12M | $-3.24M | $-2.04M | $-1.41M |
Net Income | $-1.14M | $-3.19M | $-1.97M | $-528.37K |
EPS (Diluted) | $-0.04 | $-0.74 | $-0.57 | $-0.40 |
Total Assets | $45.14M | $31.00M | $15.80M | $13.77M |
Total Liabilities | $8.12M | $8.26M | $7.49M | $7.30M |
Cash & Equivalents | $168.47K | $345.11K | $267.63K | $600.00K |
Free Cash Flow OCF − CapEx | Not available | $88.94K | $-62.60K | $175.00K |
Shares Outstanding | 40.52M | 15.52M | 3.26M | 3.26M |